🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Pertussis is an acute respiratory infectious disease caused by Bordetella p...
Status
Completed
Location
Shaanxi Center for Disease Control and Prevention
Start Date
2023-12-06
Trial ID
NCT06056050
This study is to evaluate the immunogenicity and safety of DTaP or DT given...
Status
Unknown
Location
Yiwu Center for Disease Control and Prevention
Start Date
2023-05
Trial ID
NCT05870618
Treatments Being Tested
The aim of the study is to generate additional safety and immunogenicity da...
Status
Completed
Location
Multiple Locations
Start Date
2014-03
Trial ID
NCT02089347
This clinical trial will enroll 160 participants who previously took part i...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-10-15
Trial ID
NCT07744347
It is important people receiving immunosuppressive therapy are provided wit...
Status
Recruiting
Location
Blacktown Hospital
Start Date
2023-07-21
Trial ID
NCT05415267
Treatments Being Tested
This study is to evaluate the immunogenicity and safety of DTaP or DT given...
Status
Unknown
Location
Fuyang Center for Disease Control and Prevention
Start Date
2023-05
Trial ID
NCT05870631
Treatments Being Tested
The aim of the study is to assess the immunogenicity and safety profile of ...
Status
Completed
Location
Multiple Locations
Start Date
2013-11
Trial ID
NCT01993173
Pertussis, diphtheria and tetanus are seriously infectious diseases in chil...
Status
Completed
Location
Changge Center for Disease Control and Prevention
Start Date
2020-04-28
Trial ID
NCT04099303
Treatments Being Tested
Primary objective: To demonstrate the non inferiority between REVAXIS® and...
Status
Completed
Location
Multiple Locations
Start Date
2007-02
Trial ID
NCT00447525
This study is designed to assess the immunogenicity and safety of DTaP vacc...
Status
Completed
Location
Investigational site
Start Date
2014-04
Trial ID
NCT02118961